Chrysemys picta bellii isolate RCT428 chromosome 17, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM002667.2.\nOn Aug 10, 2021 this sequence version replaced NC_024230.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
kringle containing transmembrane protein 1
COORDINATES: polyA evidence [ECO:0006239]
zinc and ring finger 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
zinc and ring finger 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc and ring finger 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc and ring finger 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
E3 ubiquitin-protein ligase ZNRF3 isoform X3
E3 ubiquitin-protein ligase ZNRF3 isoform X2
E3 ubiquitin-protein ligase ZNRF3 isoform X1
uncharacterized LOC112060490, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC112060490, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC112060490, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: X-box-binding protein 1
coiled-coil domain containing 117, transcript variant X1
coiled-coil domain containing 117, transcript variant X2
coiled-coil domain containing 117, transcript variant X3
coiled-coil domain-containing protein 117 isoform X2
coiled-coil domain-containing protein 117 isoform X1
coiled-coil domain-containing protein 117 isoform X3
solute carrier family 2, facilitated glucose transporter member 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
HscB mitochondrial iron-sulfur cluster cochaperone
iron-sulfur cluster co-chaperone protein HscB
checkpoint kinase 2, transcript variant X12
checkpoint kinase 2, transcript variant X8
checkpoint kinase 2, transcript variant X11
checkpoint kinase 2, transcript variant X20
checkpoint kinase 2, transcript variant X6
checkpoint kinase 2, transcript variant X19
checkpoint kinase 2, transcript variant X2
checkpoint kinase 2, transcript variant X3
checkpoint kinase 2, transcript variant X4
checkpoint kinase 2, transcript variant X1
serine/threonine-protein kinase Chk2 isoform X1
serine/threonine-protein kinase Chk2 isoform X3
serine/threonine-protein kinase Chk2 isoform X2
checkpoint kinase 2, transcript variant X18
checkpoint kinase 2, transcript variant X28
checkpoint kinase 2, transcript variant X17
checkpoint kinase 2, transcript variant X23
checkpoint kinase 2, transcript variant X25
checkpoint kinase 2, transcript variant X30
checkpoint kinase 2, transcript variant X14
checkpoint kinase 2, transcript variant X10
checkpoint kinase 2, transcript variant X5
checkpoint kinase 2, transcript variant X29
checkpoint kinase 2, transcript variant X24
checkpoint kinase 2, transcript variant X7
checkpoint kinase 2, transcript variant X15
checkpoint kinase 2, transcript variant X22
checkpoint kinase 2, transcript variant X9
checkpoint kinase 2, transcript variant X13
checkpoint kinase 2, transcript variant X21
checkpoint kinase 2, transcript variant X16
checkpoint kinase 2, transcript variant X26
checkpoint kinase 2, transcript variant X27
serine/threonine-protein kinase Chk2 isoform X4
serine/threonine-protein kinase Chk2 isoform X5
serine/threonine-protein kinase Chk2 isoform X6
tetratricopeptide repeat domain 28, transcript variant X1
tetratricopeptide repeat domain 28, transcript variant X2
tetratricopeptide repeat protein 28 isoform X1
tetratricopeptide repeat protein 28 isoform X2
tetratricopeptide repeat domain 28, transcript variant X5
tetratricopeptide repeat domain 28, transcript variant X4
tetratricopeptide repeat domain 28, transcript variant X3
tetratricopeptide repeat protein 28 isoform X3
tetratricopeptide repeat protein 28 isoform X4
phosphatidylinositol transfer protein beta, transcript variant X2
phosphatidylinositol transfer protein beta, transcript variant X1
phosphatidylinositol transfer protein beta isoform isoform X1
phosphatidylinositol transfer protein beta isoform isoform X2
MN1 proto-oncogene, transcriptional regulator
uncharacterized LOC122173937, transcript variant X1
uncharacterized LOC122173937, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
tyrosylprotein sulfotransferase 2, transcript variant X2
tyrosylprotein sulfotransferase 2, transcript variant X8
tyrosylprotein sulfotransferase 2, transcript variant X3
tyrosylprotein sulfotransferase 2, transcript variant X1
tyrosylprotein sulfotransferase 2, transcript variant X7
tyrosylprotein sulfotransferase 2, transcript variant X5
tyrosylprotein sulfotransferase 2, transcript variant X4
tyrosylprotein sulfotransferase 2, transcript variant X6
tyrosylprotein sulfotransferase 2, transcript variant X9
SRR1 domain containing, transcript variant X1
SRR1 domain containing, transcript variant X2
HPS4 biogenesis of lysosomal organelles complex 3 subunit 2, transcript variant X2
HPS4 biogenesis of lysosomal organelles complex 3 subunit 2, transcript variant X1
HPS4 biogenesis of lysosomal organelles complex 3 subunit 2, transcript variant X3
aspartate beta-hydroxylase domain containing 2, transcript variant X5
aspartate beta-hydroxylase domain containing 2, transcript variant X3
aspartate beta-hydroxylase domain containing 2, transcript variant X2
aspartate beta-hydroxylase domain containing 2, transcript variant X6
aspartate beta-hydroxylase domain containing 2, transcript variant X1
aspartate beta-hydroxylase domain containing 2, transcript variant X4
aspartate beta-hydroxylase domain-containing protein 2 isoform X2
aspartate beta-hydroxylase domain-containing protein 2 isoform X1
seizure related 6 homolog like, transcript variant X2
seizure related 6 homolog like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
G protein-coupled receptor kinase 3, transcript variant X1
G protein-coupled receptor kinase 3, transcript variant X2
G protein-coupled receptor kinase 3, transcript variant X3
beta-adrenergic receptor kinase 2 isoform X1
beta-adrenergic receptor kinase 2 isoform X2
beta-adrenergic receptor kinase 2 isoform X3
crystallin beta B2, transcript variant X2
crystallin beta B2, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein KIAA1671 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane protein 211
small G protein signaling modulator 1, transcript variant X1
small G protein signaling modulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
small G protein signaling modulator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
small G protein signaling modulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
small G protein signaling modulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
small G protein signaling modulator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
small G protein signaling modulator 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
small G protein signaling modulator 1 isoform X4
small G protein signaling modulator 1 isoform X7
small G protein signaling modulator 1 isoform X3
small G protein signaling modulator 1 isoform X2
small G protein signaling modulator 1 isoform X6
small G protein signaling modulator 1 isoform X1
small G protein signaling modulator 1 isoform X5
sodium-dependent serotonin transporter-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: sodium-dependent serotonin transporter-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein C12orf76 homolog
ankyrin repeat domain 13A, transcript variant X4
ankyrin repeat domain 13A, transcript variant X2
ankyrin repeat domain 13A, transcript variant X3
ankyrin repeat domain 13A, transcript variant X1
ankyrin repeat domain-containing protein 13A isoform X4
ankyrin repeat domain-containing protein 13A isoform X2
ankyrin repeat domain-containing protein 13A isoform X1
ankyrin repeat domain-containing protein 13A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ARF GTPase-activating protein GIT2 isoform X1
ARF GTPase-activating protein GIT2 isoform X5
ARF GTPase-activating protein GIT2 isoform X4
ARF GTPase-activating protein GIT2 isoform X9
ARF GTPase-activating protein GIT2 isoform X12
ARF GTPase-activating protein GIT2 isoform X2
ARF GTPase-activating protein GIT2 isoform X6
ARF GTPase-activating protein GIT2 isoform X10
ARF GTPase-activating protein GIT2 isoform X3
ARF GTPase-activating protein GIT2 isoform X13
ARF GTPase-activating protein GIT2 isoform X11
ARF GTPase-activating protein GIT2 isoform X8
ARF GTPase-activating protein GIT2 isoform X7
trichoplein keratin filament binding, transcript variant X1
trichoplein keratin filament-binding protein isoform X1
trichoplein keratin filament binding, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
trichoplein keratin filament binding, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
trichoplein keratin filament-binding protein isoform X2
trichoplein keratin filament-binding protein isoform X3
transient receptor potential cation channel subfamily V member 4, transcript variant X2
transient receptor potential cation channel subfamily V member 4, transcript variant X1
transient receptor potential cation channel subfamily V member 4
family with sequence similarity 222 member A, transcript variant X5
family with sequence similarity 222 member A, transcript variant X2
family with sequence similarity 222 member A, transcript variant X1
family with sequence similarity 222 member A, transcript variant X3
family with sequence similarity 222 member A, transcript variant X4
metabolism of cobalamin associated B, transcript variant X1
corrinoid adenosyltransferase isoform X1
metabolism of cobalamin associated B, transcript variant X2
corrinoid adenosyltransferase isoform X2
ubiquitin protein ligase E3B, transcript variant X3
ubiquitin protein ligase E3B, transcript variant X1
ubiquitin protein ligase E3B, transcript variant X2
ubiquitin protein ligase E3B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
ubiquitin protein ligase E3B, transcript variant X5
potassium channel tetramerization domain containing 10, transcript variant X1
potassium channel tetramerization domain containing 10, transcript variant X2
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 isoform X1
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
acetyl-CoA carboxylase beta, transcript variant X2
acetyl-CoA carboxylase beta, transcript variant X3
acetyl-CoA carboxylase beta, transcript variant X1
acetyl-CoA carboxylase beta, transcript variant X4
acetyl-CoA carboxylase beta, transcript variant X7
acetyl-CoA carboxylase beta, transcript variant X9
acetyl-CoA carboxylase beta, transcript variant X8
acetyl-CoA carboxylase beta, transcript variant X6
acetyl-CoA carboxylase beta, transcript variant X13
acetyl-CoA carboxylase beta, transcript variant X11
acetyl-CoA carboxylase beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acetyl-CoA carboxylase beta, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acetyl-CoA carboxylase beta, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acetyl-CoA carboxylase beta, transcript variant X14
acetyl-CoA carboxylase beta, transcript variant X17
acetyl-CoA carboxylase beta, transcript variant X15
acetyl-CoA carboxylase beta, transcript variant X12
acetyl-CoA carboxylase beta, transcript variant X18
alkB homolog 2, alpha-ketoglutarate dependent dioxygenase
ubiquitin specific peptidase 30, transcript variant X3
ubiquitin specific peptidase 30, transcript variant X2
ubiquitin specific peptidase 30, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 30 isoform X3
ubiquitin carboxyl-terminal hydrolase 30 isoform X2
ubiquitin carboxyl-terminal hydrolase 30 isoform X1
SV2 related protein, transcript variant X1
synaptic vesicle 2-related protein isoform X1
SV2 related protein, transcript variant X2
synaptic vesicle 2-related protein isoform X2
D-amino acid oxidase, transcript variant X2
D-amino acid oxidase, transcript variant X1
slingshot protein phosphatase 1, transcript variant X2
slingshot protein phosphatase 1, transcript variant X3
slingshot protein phosphatase 1, transcript variant X4
slingshot protein phosphatase 1, transcript variant X1
protein phosphatase Slingshot homolog 1 isoform X1
protein phosphatase Slingshot homolog 1 isoform X2
slingshot protein phosphatase 1, transcript variant X8
slingshot protein phosphatase 1, transcript variant X5
slingshot protein phosphatase 1, transcript variant X6
slingshot protein phosphatase 1, transcript variant X7
slingshot protein phosphatase 1, transcript variant X10
slingshot protein phosphatase 1, transcript variant X9
protein phosphatase Slingshot homolog 1 isoform X3
protein phosphatase Slingshot homolog 1 isoform X4
protein phosphatase Slingshot homolog 1 isoform X5
uncharacterized LOC122173940, transcript variant X1
uncharacterized LOC122173940, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger BED domain-containing protein 2-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: P-selectin glycoprotein ligand 1
iron-sulfur cluster assembly enzyme, transcript variant X2
iron-sulfur cluster assembly enzyme, transcript variant X1
iron-sulfur cluster assembly enzyme ISCU, mitochondrial isoform X2
iron-sulfur cluster assembly enzyme ISCU, mitochondrial isoform X1
spliceosome associated factor 3, U4/U6 recycling protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
spliceosome associated factor 3, U4/U6 recycling protein, transcript variant X2
spliceosome associated factor 3, U4/U6 recycling protein, transcript variant X1
squamous cell carcinoma antigen recognized by T-cells 3 isoform X1
squamous cell carcinoma antigen recognized by T-cells 3 isoform X2
squamous cell carcinoma antigen recognized by T-cells 3 isoform X3
FIC domain protein adenylyltransferase, transcript variant X1
FIC domain protein adenylyltransferase, transcript variant X2
FIC domain protein adenylyltransferase, transcript variant X3
protein adenylyltransferase FICD isoform X2
protein adenylyltransferase FICD isoform X1
chemerin chemokine-like receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
chemerin chemokine-like receptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
chemerin chemokine-like receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 11, transcript variant X1
protein tyrosine phosphatase non-receptor type 11, transcript variant X2
tyrosine-protein phosphatase non-receptor type 11 isoform X2
tyrosine-protein phosphatase non-receptor type 11 isoform X1
HECT domain E3 ubiquitin protein ligase 4, transcript variant X1
HECT domain E3 ubiquitin protein ligase 4, transcript variant X4
HECT domain E3 ubiquitin protein ligase 4, transcript variant X2
HECT domain E3 ubiquitin protein ligase 4, transcript variant X5
HECT domain E3 ubiquitin protein ligase 4, transcript variant X3
HECT domain E3 ubiquitin protein ligase 4, transcript variant X7
probable E3 ubiquitin-protein ligase HECTD4 isoform X1
probable E3 ubiquitin-protein ligase HECTD4 isoform X4
probable E3 ubiquitin-protein ligase HECTD4 isoform X2
probable E3 ubiquitin-protein ligase HECTD4 isoform X5
probable E3 ubiquitin-protein ligase HECTD4 isoform X3
probable E3 ubiquitin-protein ligase HECTD4 isoform X7
HECT domain E3 ubiquitin protein ligase 4, transcript variant X6
probable E3 ubiquitin-protein ligase HECTD4 isoform X6
TRAF-type zinc finger domain containing 1, transcript variant X3
TRAF-type zinc finger domain containing 1, transcript variant X2
TRAF-type zinc finger domain containing 1, transcript variant X1
TRAF-type zinc finger domain-containing protein 1 isoform X1
TRAF-type zinc finger domain-containing protein 1 isoform X2
TRAF-type zinc finger domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
N-alpha-acetyltransferase 25, NatB auxiliary subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: N-alpha-acetyltransferase 25, NatB auxiliary subunit
endoplasmic reticulum resident protein 29
transmembrane protein 116, transcript variant X4
transmembrane protein 116, transcript variant X3
transmembrane protein 116, transcript variant X5
transmembrane protein 116, transcript variant X1
transmembrane protein 116, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 20-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
MAPK activated protein kinase 5, transcript variant X1
MAPK activated protein kinase 5, transcript variant X2
MAPK activated protein kinase 5, transcript variant X3
MAP kinase-activated protein kinase 5 isoform X2
MAP kinase-activated protein kinase 5 isoform X1
MAP kinase-activated protein kinase 5 isoform X3
acyl-CoA dehydrogenase family member 10, transcript variant X3
acyl-CoA dehydrogenase family member 10, transcript variant X4
acyl-CoA dehydrogenase family member 10, transcript variant X6
acyl-CoA dehydrogenase family member 10, transcript variant X9
acyl-CoA dehydrogenase family member 10, transcript variant X5
acyl-CoA dehydrogenase family member 10, transcript variant X7
acyl-CoA dehydrogenase family member 10, transcript variant X1
acyl-CoA dehydrogenase family member 10, transcript variant X8
acyl-CoA dehydrogenase family member 10, transcript variant X2
acyl-CoA dehydrogenase family member 10 isoform X6
acyl-CoA dehydrogenase family member 10 isoform X2
acyl-CoA dehydrogenase family member 10 isoform X5
acyl-CoA dehydrogenase family member 10 isoform X3
acyl-CoA dehydrogenase family member 10 isoform X4
acyl-CoA dehydrogenase family member 10 isoform X1
acyl-CoA dehydrogenase family member 10, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
PH domain containing endocytic trafficking adaptor 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cut like homeobox 2, transcript variant X5
cut like homeobox 2, transcript variant X2
cut like homeobox 2, transcript variant X3
cut like homeobox 2, transcript variant X1
cut like homeobox 2, transcript variant X4
cut like homeobox 2, transcript variant X6
myosin regulatory light chain 2, ventricular/cardiac muscle isoform
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: coiled-coil domain-containing protein 63
protein phosphatase 1 catalytic subunit gamma
serine/threonine-protein phosphatase PP1-gamma catalytic subunit
tectonic family member 1, transcript variant X3
tectonic family member 1, transcript variant X2
tectonic family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
cell cycle checkpoint control protein RAD9B
VPS29 retromer complex component, transcript variant X2
VPS29 retromer complex component, transcript variant X1
vacuolar protein sorting-associated protein 29 isoform X1
vacuolar protein sorting-associated protein 29 isoform X2
kinetochore associated 1, transcript variant X2
kinetochore-associated protein 1 isoform X2
kinetochore associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
kinetochore associated 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
kinetochore-associated protein 1 isoform X1
kinetochore-associated protein 1 isoform X3
arginine and serine rich coiled-coil 2, transcript variant X3
arginine and serine rich coiled-coil 2, transcript variant X6
arginine and serine rich coiled-coil 2, transcript variant X1
arginine and serine rich coiled-coil 2, transcript variant X2
arginine and serine rich coiled-coil 2, transcript variant X4
arginine/serine-rich coiled-coil protein 2 isoform X1
arginine/serine-rich coiled-coil protein 2 isoform X2
arginine and serine rich coiled-coil 2, transcript variant X5
arginine/serine-rich coiled-coil protein 2 isoform X3
arginine/serine-rich coiled-coil protein 2 isoform X5
arginine/serine-rich coiled-coil protein 2 isoform X4
zinc finger CCHC-type containing 8, transcript variant X2
zinc finger CCHC-type containing 8, transcript variant X1
zinc finger CCHC domain-containing protein 8 isoform X1
zinc finger CCHC domain-containing protein 8 isoform X2
CAP-Gly domain containing linker protein 1, transcript variant X5
CAP-Gly domain containing linker protein 1, transcript variant X7
CAP-Gly domain containing linker protein 1, transcript variant X11
CAP-Gly domain containing linker protein 1, transcript variant X12
CAP-Gly domain containing linker protein 1, transcript variant X13
CAP-Gly domain containing linker protein 1, transcript variant X14
CAP-Gly domain containing linker protein 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CAP-Gly domain containing linker protein 1, transcript variant X1
CAP-Gly domain containing linker protein 1, transcript variant X6
CAP-Gly domain containing linker protein 1, transcript variant X9
CAP-Gly domain containing linker protein 1, transcript variant X8
CAP-Gly domain containing linker protein 1, transcript variant X10
CAP-Gly domain containing linker protein 1, transcript variant X22
CAP-Gly domain containing linker protein 1, transcript variant X16
CAP-Gly domain containing linker protein 1, transcript variant X17
CAP-Gly domain containing linker protein 1, transcript variant X23
CAP-Gly domain containing linker protein 1, transcript variant X18
CAP-Gly domain containing linker protein 1, transcript variant X19
CAP-Gly domain containing linker protein 1, transcript variant X20
CAP-Gly domain containing linker protein 1, transcript variant X21
CAP-Gly domain containing linker protein 1, transcript variant X3
CAP-Gly domain containing linker protein 1, transcript variant X2
CAP-Gly domain containing linker protein 1, transcript variant X4
CAP-Gly domain-containing linker protein 1 isoform X1
CAP-Gly domain-containing linker protein 1 isoform X2
CAP-Gly domain-containing linker protein 1 isoform X3
CAP-Gly domain-containing linker protein 1 isoform X4
CAP-Gly domain-containing linker protein 1 isoform X11
CAP-Gly domain-containing linker protein 1 isoform X12
CAP-Gly domain-containing linker protein 1 isoform X18
CAP-Gly domain-containing linker protein 1 isoform X8
CAP-Gly domain-containing linker protein 1 isoform X9
CAP-Gly domain-containing linker protein 1 isoform X6
CAP-Gly domain-containing linker protein 1 isoform X5
CAP-Gly domain-containing linker protein 1 isoform X13
CAP-Gly domain-containing linker protein 1 isoform X14
CAP-Gly domain-containing linker protein 1 isoform X7
CAP-Gly domain-containing linker protein 1 isoform X17
CAP-Gly domain-containing linker protein 1 isoform X15
CAP-Gly domain-containing linker protein 1 isoform X16
CAP-Gly domain-containing linker protein 1 isoform X10
VPS33A core subunit of CORVET and HOPS complexes, transcript variant X1
VPS33A core subunit of CORVET and HOPS complexes, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
vacuolar protein sorting-associated protein 33A isoform X1
vacuolar protein sorting-associated protein 33A isoform X2
diablo IAP-binding mitochondrial protein, transcript variant X2
diablo IAP-binding mitochondrial protein, transcript variant X1
diablo homolog, mitochondrial isoform X1
diablo homolog, mitochondrial isoform X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4
leucine rich repeat containing 43, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leucine rich repeat containing 43, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
leucine-rich repeat-containing protein 43 isoform X1
leucine-rich repeat-containing protein 43 isoform X2
leucine rich repeat containing 43, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
leucine rich repeat containing 43, transcript variant X3
leucine-rich repeat-containing protein 43 isoform X3
MLX interacting protein, transcript variant X3
MLX interacting protein, transcript variant X1
MLX interacting protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
MLX interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BAF chromatin remodeling complex subunit BCL7A, transcript variant X1
BAF chromatin remodeling complex subunit BCL7A, transcript variant X2
BAF chromatin remodeling complex subunit BCL7A, transcript variant X4
BAF chromatin remodeling complex subunit BCL7A, transcript variant X3
B-cell CLL/lymphoma 7 protein family member A isoform X2
B-cell CLL/lymphoma 7 protein family member A isoform X1
B-cell CLL/lymphoma 7 protein family member A isoform X4
B-cell CLL/lymphoma 7 protein family member A isoform X3
cilia and flagella associated protein 251, transcript variant X2
cilia and flagella associated protein 251, transcript variant X1
cilia and flagella associated protein 251, transcript variant X3
cilia and flagella associated protein 251, transcript variant X4
cilia- and flagella-associated protein 251 isoform X2
cilia- and flagella-associated protein 251 isoform X1
cilia- and flagella-associated protein 251 isoform X3
26S proteasome non-ATPase regulatory subunit 9
SET domain containing 1B, histone lysine methyltransferase, transcript variant X3
SET domain containing 1B, histone lysine methyltransferase, transcript variant X1
SET domain containing 1B, histone lysine methyltransferase, transcript variant X2
SET domain containing 1B, histone lysine methyltransferase, transcript variant X8
SET domain containing 1B, histone lysine methyltransferase, transcript variant X6
SET domain containing 1B, histone lysine methyltransferase, transcript variant X9
SET domain containing 1B, histone lysine methyltransferase, transcript variant X7
histone-lysine N-methyltransferase SETD1B isoform X2
histone-lysine N-methyltransferase SETD1B isoform X3
histone-lysine N-methyltransferase SETD1B isoform X1
histone-lysine N-methyltransferase SETD1B isoform X5
histone-lysine N-methyltransferase SETD1B isoform X4
SET domain containing 1B, histone lysine methyltransferase, transcript variant X4
SET domain containing 1B, histone lysine methyltransferase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ras homolog family member F, filopodia associated
transmembrane protein 120B, transcript variant X2
transmembrane protein 120B, transcript variant X1
transmembrane protein 120B, transcript variant X3
transmembrane protein 120B, transcript variant X4
transmembrane protein 120B, transcript variant X5
ORAI calcium release-activated calcium modulator 1, transcript variant X3
ORAI calcium release-activated calcium modulator 1, transcript variant X2
ORAI calcium release-activated calcium modulator 1, transcript variant X10
ORAI calcium release-activated calcium modulator 1, transcript variant X9
ORAI calcium release-activated calcium modulator 1, transcript variant X8
calcium release-activated calcium channel protein 1 isoform X2
calcium release-activated calcium channel protein 1 isoform X3
calcium release-activated calcium channel protein 1 isoform X5
ORAI calcium release-activated calcium modulator 1, transcript variant X5
ORAI calcium release-activated calcium modulator 1, transcript variant X4
ORAI calcium release-activated calcium modulator 1, transcript variant X6
ORAI calcium release-activated calcium modulator 1, transcript variant X1
ORAI calcium release-activated calcium modulator 1, transcript variant X7
calcium release-activated calcium channel protein 1 isoform X1
calcium release-activated calcium channel protein 1 isoform X4
lysine demethylase 2B, transcript variant X2
lysine demethylase 2B, transcript variant X1
lysine-specific demethylase 2B isoform X1
lysine demethylase 2B, transcript variant X4
lysine demethylase 2B, transcript variant X6
lysine demethylase 2B, transcript variant X3
lysine-specific demethylase 2B isoform X2
lysine demethylase 2B, transcript variant X5
lysine-specific demethylase 2B isoform X3
ring finger protein 34, transcript variant X2
ring finger protein 34, transcript variant X1
ring finger protein 34, transcript variant X3
E3 ubiquitin-protein ligase RNF34 isoform X3
E3 ubiquitin-protein ligase RNF34 isoform X2
E3 ubiquitin-protein ligase RNF34 isoform X1
anaphase promoting complex subunit 5, transcript variant X1
anaphase promoting complex subunit 5, transcript variant X2
anaphase-promoting complex subunit 5 isoform X1
anaphase-promoting complex subunit 5 isoform X2
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X5
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X4
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X6
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X2
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X1
calcium/calmodulin dependent protein kinase kinase 2, transcript variant X3
calcium/calmodulin-dependent protein kinase kinase 2 isoform X1
calcium/calmodulin-dependent protein kinase kinase 2 isoform X2
calcium/calmodulin-dependent protein kinase kinase 2 isoform X3
calcium/calmodulin-dependent protein kinase kinase 2 isoform X4
purinergic receptor P2X 4, transcript variant X1
purinergic receptor P2X 4, transcript variant X8
purinergic receptor P2X 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
purinergic receptor P2X 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
purinergic receptor P2X 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
purinergic receptor P2X 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
purinergic receptor P2X 4, transcript variant X4
purinergic receptor P2X 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
purinergic receptor P2X 7, transcript variant X2
purinergic receptor P2X 7, transcript variant X1
purinergic receptor P2X 7, transcript variant X3
intraflagellar transport 81, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
intraflagellar transport 81, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
intraflagellar transport 81, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
intraflagellar transport 81, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
intraflagellar transport protein 81 homolog
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2, transcript variant X2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2, transcript variant X1
sarcoplasmic/endoplasmic reticulum calcium ATPase 2
anaphase promoting complex subunit 7, transcript variant X1
anaphase promoting complex subunit 7, transcript variant X2
anaphase promoting complex subunit 7, transcript variant X3
anaphase-promoting complex subunit 7 isoform X1
anaphase-promoting complex subunit 7 isoform X2
anaphase-promoting complex subunit 7 isoform X3
actin related protein 2/3 complex subunit 3
actin-related protein 2/3 complex subunit 3
density regulated re-initiation and release factor
coiled-coil domain containing 62, transcript variant X1
coiled-coil domain containing 62, transcript variant X4
coiled-coil domain containing 62, transcript variant X3
coiled-coil domain containing 62, transcript variant X2
coiled-coil domain containing 62, transcript variant X5
coiled-coil domain-containing protein 62 isoform X1
coiled-coil domain-containing protein 62 isoform X2
coiled-coil domain-containing protein 62 isoform X3
huntingtin interacting protein 1 related
LOW QUALITY PROTEIN: huntingtin-interacting protein 1-related protein
vacuolar protein sorting-associated protein 37B
ATP binding cassette subfamily B member 9, transcript variant X4
ATP binding cassette subfamily B member 9, transcript variant X1
ATP binding cassette subfamily B member 9, transcript variant X6
ATP binding cassette subfamily B member 9, transcript variant X3
ATP binding cassette subfamily B member 9, transcript variant X2
ATP binding cassette subfamily B member 9, transcript variant X5
ABC-type oligopeptide transporter ABCB9 isoform X2
ABC-type oligopeptide transporter ABCB9 isoform X1
ABC-type oligopeptide transporter ABCB9 isoform X4
ABC-type oligopeptide transporter ABCB9 isoform X3
2-oxoglutarate and iron dependent oxygenase domain containing 2, transcript variant X1
2-oxoglutarate and iron dependent oxygenase domain containing 2, transcript variant X2
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 isoform X2
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 isoform X1
2-oxoglutarate and iron dependent oxygenase domain containing 2, transcript variant X3
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 isoform X3
ADP ribosylation factor like GTPase 6 interacting protein 4, transcript variant X2
ADP ribosylation factor like GTPase 6 interacting protein 4, transcript variant X1
ADP ribosylation factor like GTPase 6 interacting protein 4, transcript variant X3
ADP-ribosylation factor-like protein 6-interacting protein 4 isoform X1
ADP-ribosylation factor-like protein 6-interacting protein 4 isoform X3
ADP-ribosylation factor-like protein 6-interacting protein 4 isoform X2
phosphatidylinositol transfer protein membrane associated 2, transcript variant X9
phosphatidylinositol transfer protein membrane associated 2, transcript variant X5
phosphatidylinositol transfer protein membrane associated 2, transcript variant X7
phosphatidylinositol transfer protein membrane associated 2, transcript variant X10
phosphatidylinositol transfer protein membrane associated 2, transcript variant X6
phosphatidylinositol transfer protein membrane associated 2, transcript variant X13
phosphatidylinositol transfer protein membrane associated 2, transcript variant X8
phosphatidylinositol transfer protein membrane associated 2, transcript variant X11
phosphatidylinositol transfer protein membrane associated 2, transcript variant X1
phosphatidylinositol transfer protein membrane associated 2, transcript variant X14
phosphatidylinositol transfer protein membrane associated 2, transcript variant X12
phosphatidylinositol transfer protein membrane associated 2, transcript variant X16
phosphatidylinositol transfer protein membrane associated 2, transcript variant X2
phosphatidylinositol transfer protein membrane associated 2, transcript variant X3
phosphatidylinositol transfer protein membrane associated 2, transcript variant X4
phosphatidylinositol transfer protein membrane associated 2, transcript variant X15
membrane-associated phosphatidylinositol transfer protein 2 isoform X11
membrane-associated phosphatidylinositol transfer protein 2 isoform X7
membrane-associated phosphatidylinositol transfer protein 2 isoform X9
membrane-associated phosphatidylinositol transfer protein 2 isoform X3
membrane-associated phosphatidylinositol transfer protein 2 isoform X13
membrane-associated phosphatidylinositol transfer protein 2 isoform X6
membrane-associated phosphatidylinositol transfer protein 2 isoform X10
membrane-associated phosphatidylinositol transfer protein 2 isoform X5
membrane-associated phosphatidylinositol transfer protein 2 isoform X2
membrane-associated phosphatidylinositol transfer protein 2 isoform X8
membrane-associated phosphatidylinositol transfer protein 2 isoform X4
membrane-associated phosphatidylinositol transfer protein 2 isoform X1
membrane-associated phosphatidylinositol transfer protein 2 isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phosphatidylinositol transfer protein membrane associated 2, transcript variant X17
membrane-associated phosphatidylinositol transfer protein 2 isoform X14
M-phase phosphoprotein 9, transcript variant X1
M-phase phosphoprotein 9, transcript variant X2
M-phase phosphoprotein 9, transcript variant X3
M-phase phosphoprotein 9, transcript variant X5
M-phase phosphoprotein 9, transcript variant X4
mitochondrial translation release factor in rescue, transcript variant X3
mitochondrial translation release factor in rescue, transcript variant X2
mitochondrial translation release factor in rescue, transcript variant X1
mitochondrial translation release factor in rescue
cyclin dependent kinase 2 associated protein 1, transcript variant X2
cyclin dependent kinase 2 associated protein 1, transcript variant X1
cyclin-dependent kinase 2-associated protein 1 isoform X1
cyclin-dependent kinase 2-associated protein 1 isoform X2
strawberry notch homolog 1, transcript variant X2
strawberry notch homolog 1, transcript variant X3
strawberry notch homolog 1, transcript variant X5
strawberry notch homolog 1, transcript variant X4
strawberry notch homolog 1, transcript variant X1
protein strawberry notch homolog 1 isoform X2
protein strawberry notch homolog 1 isoform X1
lysine methyltransferase 5A, transcript variant X3
lysine methyltransferase 5A, transcript variant X1
lysine methyltransferase 5A, transcript variant X2
N-lysine methyltransferase KMT5A isoform X3
N-lysine methyltransferase KMT5A isoform X1
N-lysine methyltransferase KMT5A isoform X2
lysine methyltransferase 5A, transcript variant X4
N-lysine methyltransferase KMT5A isoform X4
Rab interacting lysosomal protein like 2
small nuclear ribonucleoprotein U11/U12 subunit 35, transcript variant X2
small nuclear ribonucleoprotein U11/U12 subunit 35, transcript variant X1
U11/U12 small nuclear ribonucleoprotein 35 kDa protein
Rab interacting lysosomal protein like 1, transcript variant X5
Rab interacting lysosomal protein like 1, transcript variant X7
Rab interacting lysosomal protein like 1, transcript variant X1
Rab interacting lysosomal protein like 1, transcript variant X2
Rab interacting lysosomal protein like 1, transcript variant X3
Rab interacting lysosomal protein like 1, transcript variant X4
Rab interacting lysosomal protein like 1, transcript variant X6
transmembrane p24 trafficking protein 2, transcript variant X1
transmembrane p24 trafficking protein 2, transcript variant X2
transmembrane emp24 domain-containing protein 2 isoform X1
transmembrane emp24 domain-containing protein 2 isoform X2
eukaryotic translation initiation factor 2B subunit alpha
translation initiation factor eIF-2B subunit alpha
general transcription factor IIH subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
dynein axonemal heavy chain 10, transcript variant X1
dynein axonemal heavy chain 10, transcript variant X2
dynein axonemal heavy chain 10, transcript variant X3
dynein axonemal heavy chain 10 isoform X1
dynein axonemal heavy chain 10 isoform X2
dynein axonemal heavy chain 10 isoform X3
coiled-coil domain containing 92, transcript variant X2
coiled-coil domain containing 92, transcript variant X1
coiled-coil domain containing 92, transcript variant X7
coiled-coil domain containing 92, transcript variant X5
coiled-coil domain containing 92, transcript variant X6
coiled-coil domain containing 92, transcript variant X4
coiled-coil domain containing 92, transcript variant X9
coiled-coil domain containing 92, transcript variant X8
coiled-coil domain containing 92, transcript variant X3
coiled-coil domain-containing protein 92 isoform X1
coiled-coil domain-containing protein 92 isoform X2
coiled-coil domain-containing protein 92 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
scavenger receptor class B member 1, transcript variant X4
scavenger receptor class B member 1, transcript variant X3
scavenger receptor class B member 1, transcript variant X1
scavenger receptor class B member 1, transcript variant X5
scavenger receptor class B member 1 isoform X4
scavenger receptor class B member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
scavenger receptor class B member 1 isoform X3
scavenger receptor class B member 1 isoform X1
scavenger receptor class B member 1 isoform X5
scavenger receptor class B member 1 isoform X2
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
probable ATP-dependent RNA helicase DHX37
transmembrane protein 132B, transcript variant X1
transmembrane protein 132B, transcript variant X2
transmembrane protein 132C, transcript variant X2
transmembrane protein 132C, transcript variant X1
transmembrane protein 132C, transcript variant X3
transmembrane protein 132C, transcript variant X4
solute carrier family 15 member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 15 member 4 isoform X4
solute carrier family 15 member 4, transcript variant X2
solute carrier family 15 member 4, transcript variant X1
solute carrier family 15 member 4 isoform X2
solute carrier family 15 member 4 isoform X1
solute carrier family 15 member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
solute carrier family 15 member 4 isoform X3
glycosyltransferase 1 domain containing 1
glycosyltransferase 1 domain-containing protein 1
LOW QUALITY PROTEIN: transmembrane protein 132D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
piwi like RNA-mediated gene silencing 1, transcript variant X1
piwi like RNA-mediated gene silencing 1, transcript variant X2
piwi like RNA-mediated gene silencing 1, transcript variant X3
RIMS binding protein 2, transcript variant X1
RIMS binding protein 2, transcript variant X2
RIMS binding protein 2, transcript variant X3
RIMS binding protein 2, transcript variant X5
RIMS binding protein 2, transcript variant X4
RIMS binding protein 2, transcript variant X8
RIMS binding protein 2, transcript variant X6
RIMS binding protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor D1, transcript variant X1
adhesion G protein-coupled receptor D1, transcript variant X2
adhesion G-protein coupled receptor D1 isoform X1
adhesion G-protein coupled receptor D1 isoform X2
adhesion G protein-coupled receptor D1, transcript variant X4
adhesion G protein-coupled receptor D1, transcript variant X3
adhesion G-protein coupled receptor D1 isoform X3
uncharacterized LOC101951802, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC101951802, transcript variant X1
uncharacterized LOC101951802, transcript variant X5
uncharacterized LOC101951802, transcript variant X2
uncharacterized LOC101951802, transcript variant X4
splicing factor SWAP, transcript variant X1
splicing factor SWAP, transcript variant X2
splicing factor SWAP, transcript variant X4
splicing factor SWAP, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
splicing factor SWAP, transcript variant X3
splicing factor, suppressor of white-apricot homolog isoform X1
splicing factor, suppressor of white-apricot homolog isoform X3
splicing factor, suppressor of white-apricot homolog isoform X2
splicing factor, suppressor of white-apricot homolog isoform X4
splicing factor, suppressor of white-apricot homolog isoform X5
splicing factor SWAP, transcript variant X8
splicing factor SWAP, transcript variant X6
splicing factor SWAP, transcript variant X7
splicing factor, suppressor of white-apricot homolog isoform X6
matrix metallopeptidase 17, transcript variant X1
matrix metallopeptidase 17, transcript variant X2
unc-51 like autophagy activating kinase 1
LOW QUALITY PROTEIN: serine/threonine-protein kinase ULK1
pseudouridine synthase 1, transcript variant X2
pseudouridine synthase 1, transcript variant X1
tRNA pseudouridine synthase A isoform X2
tRNA pseudouridine synthase A isoform X1
E1A-binding protein p400-like, transcript variant X6
E1A-binding protein p400-like, transcript variant X5
E1A-binding protein p400-like, transcript variant X8
E1A-binding protein p400-like, transcript variant X9
E1A-binding protein p400-like, transcript variant X7
E1A-binding protein p400-like, transcript variant X1
E1A-binding protein p400-like, transcript variant X3
E1A-binding protein p400-like, transcript variant X2
E1A-binding protein p400-like, transcript variant X4
E1A-binding protein p400-like isoform X1
E1A-binding protein p400-like isoform X3
E1A-binding protein p400-like isoform X4
E1A-binding protein p400-like isoform X2
E1A-binding protein p400-like, transcript variant X10
E1A-binding protein p400-like isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00562
E1A-binding protein p400, transcript variant X1
E1A-binding protein p400, transcript variant X10
E1A-binding protein p400, transcript variant X6
E1A-binding protein p400, transcript variant X9
E1A-binding protein p400, transcript variant X3
E1A-binding protein p400, transcript variant X8
E1A-binding protein p400, transcript variant X5
E1A-binding protein p400, transcript variant X7
E1A-binding protein p400, transcript variant X4
E1A-binding protein p400, transcript variant X15
E1A-binding protein p400, transcript variant X11
E1A-binding protein p400, transcript variant X12
E1A-binding protein p400, transcript variant X17
E1A-binding protein p400, transcript variant X13
E1A-binding protein p400, transcript variant X16
E1A-binding protein p400, transcript variant X14
E1A-binding protein p400, transcript variant X2
nucleolar complex associated 4 homolog, transcript variant X1
nucleolar complex associated 4 homolog, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 9 isoform X1
polypeptide N-acetylgalactosaminyltransferase 9 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
checkpoint with forkhead and ring finger domains, transcript variant X5
checkpoint with forkhead and ring finger domains, transcript variant X6
checkpoint with forkhead and ring finger domains, transcript variant X1
checkpoint with forkhead and ring finger domains, transcript variant X9
checkpoint with forkhead and ring finger domains, transcript variant X8
checkpoint with forkhead and ring finger domains, transcript variant X7
checkpoint with forkhead and ring finger domains, transcript variant X2
checkpoint with forkhead and ring finger domains, transcript variant X4
checkpoint with forkhead and ring finger domains, transcript variant X3
checkpoint with forkhead and ring finger domains, transcript variant X10
E3 ubiquitin-protein ligase CHFR isoform X1
E3 ubiquitin-protein ligase CHFR isoform X4
E3 ubiquitin-protein ligase CHFR isoform X3
E3 ubiquitin-protein ligase CHFR isoform X2
E3 ubiquitin-protein ligase CHFR isoform X5
uncharacterized LOC101932741, transcript variant X1
uncharacterized LOC101932741, transcript variant X2
uncharacterized protein LOC101932741 isoform X1
uncharacterized protein LOC101932741 isoform X2
uncharacterized LOC101932741, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized protein LOC101932741 isoform X3
fasciculation and elongation protein zeta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and LEM domain containing 2, transcript variant X4
ankyrin repeat and LEM domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ankyrin repeat and LEM domain containing 2, transcript variant X2
ankyrin repeat and LEM domain containing 2, transcript variant X1
ankyrin repeat and LEM domain-containing protein 2 isoform X3
ankyrin repeat and LEM domain-containing protein 2 isoform X1
ankyrin repeat and LEM domain-containing protein 2 isoform X2
ankyrin repeat and LEM domain-containing protein 2 isoform X4
zinc finger DHHC-type palmitoyltransferase 8, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 8, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 8, transcript variant X6
zinc finger DHHC-type palmitoyltransferase 8, transcript variant X5
zinc finger DHHC-type palmitoyltransferase 8, transcript variant X4
zinc finger DHHC-type palmitoyltransferase 8, transcript variant X3
RAN binding protein 1, transcript variant X1
RAN binding protein 1, transcript variant X2
ran-specific GTPase-activating protein isoform X2
ran-specific GTPase-activating protein isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00599
tRNA methyltransferase 2 homolog A, transcript variant X1
tRNA (uracil-5-)-methyltransferase homolog A isoform X1
tRNA methyltransferase 2 homolog A, transcript variant X3
tRNA methyltransferase 2 homolog A, transcript variant X2
tRNA (uracil-5-)-methyltransferase homolog A isoform X2
tRNA (uracil-5-)-methyltransferase homolog A isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
DGCR8 microprocessor complex subunit, transcript variant X2
DGCR8 microprocessor complex subunit, transcript variant X1
microprocessor complex subunit DGCR8 isoform X1
DGCR8 microprocessor complex subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
microprocessor complex subunit DGCR8 isoform X2
transport and golgi organization 2 homolog, transcript variant X3
transport and golgi organization 2 homolog, transcript variant X6
transport and golgi organization 2 homolog, transcript variant X1
transport and golgi organization 2 homolog, transcript variant X4
transport and golgi organization 2 homolog, transcript variant X8
transport and golgi organization 2 homolog, transcript variant X7
transport and golgi organization 2 homolog, transcript variant X2
transport and golgi organization 2 homolog, transcript variant X10
transport and golgi organization 2 homolog, transcript variant X11
transport and golgi organization 2 homolog, transcript variant X5
transport and Golgi organization protein 2 homolog isoform X1
transport and Golgi organization protein 2 homolog isoform X2
transport and Golgi organization protein 2 homolog isoform X4
transport and golgi organization 2 homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transport and Golgi organization protein 2 homolog isoform X3
uncharacterized LOC101943848, transcript variant X1
uncharacterized LOC101943848, transcript variant X3
uncharacterized LOC101943848, transcript variant X2
protein tyrosine phosphatase mitochondrial 1, transcript variant X2
protein tyrosine phosphatase mitochondrial 1, transcript variant X1
phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 isoform X1
phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 isoform X2
kelch repeat and BTB domain containing 4, transcript variant X2
kelch repeat and BTB domain containing 4, transcript variant X1
kelch repeat and BTB domain containing 4, transcript variant X4
kelch repeat and BTB domain containing 4, transcript variant X3
kelch repeat and BTB domain-containing protein 4 isoform X2
kelch repeat and BTB domain-containing protein 4 isoform X1
kelch repeat and BTB domain-containing protein 4 isoform X3
NADH:ubiquinone oxidoreductase core subunit S3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial
family with sequence similarity 180 member B
C1q and TNF related 4, transcript variant X4
C1q and TNF related 4, transcript variant X1
C1q and TNF related 4, transcript variant X3
C1q and TNF related 4, transcript variant X2
complement C1q tumor necrosis factor-related protein 4
C1q and TNF related 4, transcript variant X5
alpha-(1,6)-fucosyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
alpha-(1,6)-fucosyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
alpha-(1,6)-fucosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
alpha-(1,6)-fucosyltransferase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glycine N-acyltransferase-like protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 378 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
formin binding protein 4, transcript variant X2
formin binding protein 4, transcript variant X1
formin binding protein 4, transcript variant X3
nuclear pore complex protein Nup160 isoform X2
nuclear pore complex protein Nup160 isoform X1
pleckstrin homology and RhoGEF domain containing G3
pleckstrin homology domain-containing family G member 3
spectrin beta, erythrocytic, transcript variant X6
spectrin beta, erythrocytic, transcript variant X4
spectrin beta, erythrocytic, transcript variant X1
spectrin beta, erythrocytic, transcript variant X5
spectrin beta, erythrocytic, transcript variant X2
spectrin beta, erythrocytic, transcript variant X3
spectrin beta, erythrocytic, transcript variant X8
spectrin beta, erythrocytic, transcript variant X7
spectrin beta chain, erythrocytic isoform X4
spectrin beta chain, erythrocytic isoform X2
spectrin beta chain, erythrocytic isoform X1
spectrin beta chain, erythrocytic isoform X6
spectrin beta chain, erythrocytic isoform X5
spectrin beta chain, erythrocytic isoform X3
spectrin beta, erythrocytic, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
spectrin beta chain, erythrocytic isoform X7
spectrin beta, erythrocytic, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
spectrin beta chain, erythrocytic isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
protein farnesyltransferase subunit beta
MYC associated factor X, transcript variant X2
MYC associated factor X, transcript variant X1
MYC associated factor X, transcript variant X3
MYC associated factor X, transcript variant X4
unc-93 homolog B1, TLR signaling regulator
aldehyde dehydrogenase family 3 member B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
aldehyde dehydrogenase family 3 member B1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
aldehyde dehydrogenase family 3 member B1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
aldehyde dehydrogenase family 3 member B1-like
NADH:ubiquinone oxidoreductase core subunit S8, transcript variant X1
NADH:ubiquinone oxidoreductase core subunit S8, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial
T cell immune regulator 1, ATPase H+ transporting V0 subunit a3, transcript variant X2
T cell immune regulator 1, ATPase H+ transporting V0 subunit a3, transcript variant X1
V-type proton ATPase 116 kDa subunit a3 isoform X1
V-type proton ATPase 116 kDa subunit a3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
snaclec coagulation factor X-activating enzyme light chain 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase DTX4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine protease FAM111A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
ZFP91 zinc finger protein, atypical E3 ubiquitin ligase, transcript variant X2
ZFP91 zinc finger protein, atypical E3 ubiquitin ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
olfactory receptor 1020-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
olfactory receptor 1020-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
thioredoxin related transmembrane protein 2, transcript variant X1
thioredoxin related transmembrane protein 2, transcript variant X2
thioredoxin related transmembrane protein 2, transcript variant X3
thioredoxin-related transmembrane protein 2 isoform X1
thioredoxin-related transmembrane protein 2 isoform X2
LOW QUALITY PROTEIN: mediator of RNA polymerase II transcription subunit 19
zinc finger DHHC-type palmitoyltransferase 5, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 5, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 5, transcript variant X3
cleavage factor polyribonucleotide kinase subunit 1, transcript variant X1
cleavage factor polyribonucleotide kinase subunit 1, transcript variant X3
cleavage factor polyribonucleotide kinase subunit 1, transcript variant X2
cleavage factor polyribonucleotide kinase subunit 1, transcript variant X4
cleavage factor polyribonucleotide kinase subunit 1, transcript variant X5
polyribonucleotide 5'-hydroxyl-kinase Clp1 isoform X3
polyribonucleotide 5'-hydroxyl-kinase Clp1 isoform X1
polyribonucleotide 5'-hydroxyl-kinase Clp1 isoform X2
ubiquitin conjugating enzyme E2 L6, transcript variant X1
ubiquitin conjugating enzyme E2 L6, transcript variant X2
ubiquitin/ISG15-conjugating enzyme E2 L6 isoform X1
ubiquitin/ISG15-conjugating enzyme E2 L6 isoform X2
smoothelin like 1, transcript variant X2
smoothelin like 1, transcript variant X1
smoothelin like 1, transcript variant X3
translocase of inner mitochondrial membrane 10
mitochondrial import inner membrane translocase subunit Tim10
solute carrier family 43 member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
solute carrier family 43 member 1, transcript variant X4
solute carrier family 43 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
solute carrier family 43 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
solute carrier family 43 member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
large neutral amino acids transporter small subunit 3 isoform X2
large neutral amino acids transporter small subunit 3 isoform X1
large neutral amino acids transporter small subunit 3 isoform X3
solute carrier family 43 member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
large neutral amino acids transporter small subunit 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
structure specific recognition protein 1, transcript variant X1
structure specific recognition protein 1, transcript variant X2
tankyrase 1 binding protein 1, transcript variant X3
tankyrase 1 binding protein 1, transcript variant X1
tankyrase 1 binding protein 1, transcript variant X4
tankyrase 1 binding protein 1, transcript variant X5
tankyrase 1 binding protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tankyrase 1 binding protein 1, transcript variant X2
182 kDa tankyrase-1-binding protein isoform X1
182 kDa tankyrase-1-binding protein isoform X2
182 kDa tankyrase-1-binding protein isoform X3
182 kDa tankyrase-1-binding protein isoform X4
mas-related G-protein coupled receptor member H-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mas-related G-protein coupled receptor member H-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mas-related G-protein coupled receptor member H-like isoform X1
mas-related G-protein coupled receptor member H-like isoform X2
leucine rich repeat containing 55, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
leucine rich repeat containing 55, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
leucine-rich repeat-containing protein 55
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 229 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 223 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 335 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 112 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
nerve growth factor, transcript variant X7
nerve growth factor, transcript variant X3
nerve growth factor, transcript variant X2
nerve growth factor, transcript variant X4
nerve growth factor, transcript variant X1
nerve growth factor, transcript variant X5
nerve growth factor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nerve growth factor, transcript variant X6
nerve growth factor, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
thyroid stimulating hormone subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: synaptonemal complex protein 1
bile acid receptor-like, transcript variant X5
bile acid receptor-like, transcript variant X2
bile acid receptor-like, transcript variant X1
bile acid receptor-like, transcript variant X4
bile acid receptor-like, transcript variant X3
bile acid receptor-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
suppressor of IKBKE 1, transcript variant X2
suppressor of IKBKE 1, transcript variant X1
suppressor of IKBKE 1, transcript variant X3
cold shock domain containing E1, transcript variant X1
cold shock domain containing E1, transcript variant X2
cold shock domain containing E1, transcript variant X4
cold shock domain containing E1, transcript variant X3
cold shock domain-containing protein E1 isoform X1
cold shock domain-containing protein E1 isoform X2
cold shock domain-containing protein E1 isoform X3
NRAS proto-oncogene, GTPase, transcript variant X1
NRAS proto-oncogene, GTPase, transcript variant X2
adenosine monophosphate deaminase 1, transcript variant X1
adenosine monophosphate deaminase 1, transcript variant X2
adenosine monophosphate deaminase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X2
DENN domain containing 2C, transcript variant X8
DENN domain containing 2C, transcript variant X7
DENN domain containing 2C, transcript variant X4
DENN domain containing 2C, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X11
DENN domain containing 2C, transcript variant X13
DENN domain containing 2C, transcript variant X1
DENN domain containing 2C, transcript variant X3
DENN domain containing 2C, transcript variant X5
DENN domain containing 2C, transcript variant X6
DENN domain containing 2C, transcript variant X9
DENN domain containing 2C, transcript variant X10
DENN domain-containing protein 2C isoform X1
DENN domain-containing protein 2C isoform X2
homeodomain interacting protein kinase 1, transcript variant X4
homeodomain interacting protein kinase 1, transcript variant X3
homeodomain interacting protein kinase 1, transcript variant X2
homeodomain interacting protein kinase 1, transcript variant X1
homeodomain-interacting protein kinase 1 isoform X4
homeodomain-interacting protein kinase 1 isoform X3
homeodomain-interacting protein kinase 1 isoform X2
homeodomain-interacting protein kinase 1 isoform X1
uncharacterized LOC103306337, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC103306337, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
DNA cross-link repair 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
DNA cross-link repair 1B, transcript variant X3
DNA cross-link repair 1B, transcript variant X4
DNA cross-link repair 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adaptor related protein complex 4 subunit beta 1, transcript variant X2
adaptor related protein complex 4 subunit beta 1, transcript variant X1
adaptor related protein complex 4 subunit beta 1, transcript variant X3
polymeric immunoglobulin receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase non-receptor type 22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 22 isoform X1
protein tyrosine phosphatase non-receptor type 22, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 22 isoform X2
polymeric immunoglobulin receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 566-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger protein 566-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
zinc finger protein 566-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
zinc finger protein 566-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
putative homeodomain transcription factor 1, transcript variant X5
putative homeodomain transcription factor 1, transcript variant X1
putative homeodomain transcription factor 1, transcript variant X4
putative homeodomain transcription factor 1, transcript variant X6
putative homeodomain transcription factor 1, transcript variant X7
putative homeodomain transcription factor 1, transcript variant X2
putative homeodomain transcription factor 1, transcript variant X3
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X6
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X3
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X7
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X4
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X8
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X5
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X1
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X9
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X10
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X3
uncharacterized LOC112060015, transcript variant X1
uncharacterized LOC112060015, transcript variant X2
leucine rich repeats and immunoglobulin like domains 2, transcript variant X2
leucine rich repeats and immunoglobulin like domains 2, transcript variant X1
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X2
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X1
solute carrier family 16 member 1, transcript variant X2
solute carrier family 16 member 1, transcript variant X1
TAFA chemokine like family member 3, transcript variant X2
TAFA chemokine like family member 3, transcript variant X1
protein phosphatase, Mg2+/Mn2+ dependent 1J
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
capping actin protein of muscle Z-line subunit alpha 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X3
suppression of tumorigenicity 7 like, transcript variant X1
suppressor of tumorigenicity 7 protein-like isoform X2
suppressor of tumorigenicity 7 protein-like isoform X3
suppressor of tumorigenicity 7 protein-like isoform X1
CTTNBP2 N-terminal like, transcript variant X1
CTTNBP2 N-terminal like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
CTTNBP2 N-terminal-like protein isoform X1
CTTNBP2 N-terminal-like protein isoform X2
potassium voltage-gated channel subfamily D member 3, transcript variant X1
potassium voltage-gated channel subfamily D member 3, transcript variant X3
potassium voltage-gated channel subfamily D member 3, transcript variant X2
potassium voltage-gated channel subfamily D member 3 isoform X1
potassium voltage-gated channel subfamily D member 3 isoform X2
potassium voltage-gated channel subfamily D member 3 isoform X3
probable ATP-dependent RNA helicase DDX20
inka box actin regulator 2, transcript variant X1
inka box actin regulator 2, transcript variant X2
RAP1A, member of RAS oncogene family, transcript variant X2
RAP1A, member of RAS oncogene family, transcript variant X3
RAP1A, member of RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase peripheral stalk-membrane subunit b
ATP synthase F(0) complex subunit B1, mitochondrial
LOW QUALITY PROTEIN: uncharacterized protein C6orf132 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
putative uncharacterized protein GUCA1ANB
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
interferon regulatory factor 6, transcript variant X2
interferon regulatory factor 6, transcript variant X4
interferon regulatory factor 6, transcript variant X5
interferon regulatory factor 6, transcript variant X3
interferon regulatory factor 6 isoform X2
interferon regulatory factor 6, transcript variant X1
interferon regulatory factor 6 isoform X1
chromosome 17 C1orf74 homolog, transcript variant X6
chromosome 17 C1orf74 homolog, transcript variant X4
chromosome 17 C1orf74 homolog, transcript variant X1
chromosome 17 C1orf74 homolog, transcript variant X7
chromosome 17 C1orf74 homolog, transcript variant X5
chromosome 17 C1orf74 homolog, transcript variant X3
chromosome 17 C1orf74 homolog, transcript variant X2
TRAF3 interacting protein 3, transcript variant X2
TRAF3 interacting protein 3, transcript variant X1
TRAF3 interacting protein 3, transcript variant X6
TRAF3 interacting protein 3, transcript variant X4
TRAF3 interacting protein 3, transcript variant X3
TRAF3 interacting protein 3, transcript variant X5
TRAF3-interacting JNK-activating modulator isoform X2
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3 interacting protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1-like isoform X2
corticosteroid 11-beta-dehydrogenase isozyme 1-like isoform X1
laminin subunit beta 3, transcript variant X2
laminin subunit beta 3, transcript variant X1
laminin subunit beta 3, transcript variant X4
laminin subunit beta 3, transcript variant X3
calcium/calmodulin dependent protein kinase IG, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
calcium/calmodulin dependent protein kinase IG, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1G
olfactory receptor class A-like protein 1